Zobrazeno 1 - 10 of 332 pro vyhledávání: '"Omgo E Nieweg"'
2
Akademický článek
Telehealth follow‐up consultations for melanoma patients during the COVID‐19 pandemic: Patient and clinician satisfaction
Autor: Ali Al‐Rikaby, Ahmad Sulaiman, Jake R. Thompson, Robyn P. M. Saw, Frances Boyle, Nicole Taylor, Matteo S. Carlino, Rachael L. Morton, Omgo E. Nieweg, John F. Thompson, Iris Bartula
Publikováno v: Cancer Medicine, Vol 12, Iss 23, Pp 21373-21388 (2023)
Abstract Introduction The COVID‐19 pandemic caused rapid implementation of telehealth for melanoma follow‐up care in Australia. This study explores Australian melanoma patients and clinicians' level of satisfaction with telehealth. Methods A cros
Externí odkaz: https://doaj.org/article/bd7eabcf48414daab330a8b547ad8cbd
Zobrazit plný text záznamu
3
Akademický článek
Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting
Autor: Mathias Seviiri, Richard A. Scolyer, D. Timothy Bishop, Julia A. Newton-Bishop, Mark M. Iles, Serigne N. Lo, Johnathan R. Stretch, Robyn P. M. Saw, Omgo E. Nieweg, Kerwin F. Shannon, Andrew J. Spillane, Scott D. Gordon, Catherine M. Olsen, David C. Whiteman, Maria Teresa Landi, John F. Thompson, Georgina V. Long, Stuart MacGregor, Matthew H. Law
Publikováno v: Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background The role of germline genetic factors in determining survival from cutaneous melanoma (CM) is not well understood. Objective To perform a genome-wide association study (GWAS) meta-analysis of melanoma-specific survival (MSS), and t
Externí odkaz: https://doaj.org/article/ef000a44851f4e28a8d7423a1ed25890
Zobrazit plný text záznamu
4
Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection
Autor: Lodewijka H. J. Holtkamp, Serigne N. Lo, John F. Thompson, Andrew J. Spillane, Jonathan R. Stretch, Robyn P. M. Saw, Kerwin F. Shannon, Omgo E. Nieweg, Angela M. Hong
Publikováno v: Journal of Surgical Oncology. 128(1):97-104
Background and Objectives: Adjuvant radiotherapy (RT) can be given to melanoma patients following salvage surgery for node field recurrence after a previous regional node dissection, but the value of this treatment strategy is poorly documented. This
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0f1641945ff449c3ad8aa56f1208e0c
https://research.rug.nl/en/publications/6166b57b-bea0-4ee0-9836-1062e58fbcc9
Zobrazit plný text záznamu
8
Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases
Autor: Anna K. Lawless, David J. Coker, Serigne N. Lo, Tasnia Ahmed, Richard A. Scolyer, Sydney Ch’ng, Omgo E. Nieweg, Kerwin Shannon, Andrew Spillane, Jonathan R. Stretch, John F. Thompson, Robyn P. M. Saw
Publikováno v: Annals of Surgical Oncology. 29:7019-7028
Background In-transit metastases (ITMs) affect approximately 4% of patients with cutaneous melanoma. This study sought to identify clinical and pathological characteristics that predict further recurrence and survival following resection of ITMs. Pat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4984a0660319ca8ba7ee9713a1df94e5
https://doi.org/10.1245/s10434-022-11997-0
Zobrazit plný text záznamu
9
Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients
Autor: Mary-Ann El Sharouni, Richard A. Scolyer, Carla H. van Gils, Sydney Ch’ng, Omgo E. Nieweg, Thomas E. Pennington, Robyn PM. Saw, Kerwin Shannon, Andrew Spillane, Jonathan Stretch, Arjen J. Witkamp, Vigfús Sigurdsson, John F. Thompson, Paul J. van Diest, Serigne N. Lo
Publikováno v: European Journal of Cancer. 167:133-141
This study sought to assess whether the interval between diagnostic excision-biopsy of a primary melanoma and definitive wide excision with sentinel node biopsy (SNB) influenced the size of SN metastatic deposits, which might have implications for ma
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2352230be6c1827005a00a3b0c3aaf15
https://doi.org/10.1016/j.ejca.2021.12.036
Zobrazit plný text záznamu
10
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting
Autor: Richard A. Scolyer, Victoria Atkinson, David E. Gyorki, Duncan Lambie, Sandra O'Toole, Robyn P.M. Saw, Benhur Amanuel, Christopher M. Angel, Alison E. Button-Sloan, Matteo S. Carlino, Sydney Ch'ng, Andrew J. Colebatch, Dariush Daneshvar, Inês Pires da Silva, Tamara Dawson, Peter M. Ferguson, Erwin Foster-Smith, Stephen B. Fox, Anthony J. Gill, Ruta Gupta, Michael A. Henderson, Angela M. Hong, Julie R. Howle, Louise A. Jackett, Craig James, C. Soon Lee, Alistair Lochhead, Daphne Loh, Grant A. McArthur, Catriona A. McLean, Alexander M. Menzies, Omgo E. Nieweg, Blake H. O'Brien, Thomas E. Pennington, Alison J. Potter, Saurabh Prakash, Robert V. Rawson, Rebecca L. Read, Michael A. Rtshiladze, Kerwin F. Shannon, B. Mark Smithers, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Paul Tucker, Alexander H.R. Varey, Ricardo E. Vilain, Benjamin A. Wood, Georgina V. Long
Publikováno v: Pathology. 54:6-19
Targeted therapy (BRAF inhibitor plus MEK inhibitor) is now among the possible treatment options for patients with BRAF mutation-positive stage III or stage IV melanoma. This makes prompt BRAF mutation testing an important step in the management of p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::243fdb599ad455fbebe5d3581b83ba4f
https://doi.org/10.1016/j.pathol.2021.11.002
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje